Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Cell Counting ...

Seattle-based Rad Power Bikes, a pioneer in mass-market e-bikes, filed for bankruptcy protection earlier this week as it continues to look for a buyer amid falling sales and massive debt. Court ...

Xbiom™ Platform Introduces AI-Enabled Automated Workflow that Eliminates Redundant Processes, Reduces Costs by 50%, and Accelerates IND-Enabling Regulatory Submission Readiness by 2-4 Weeks Foster ...

Electric bike company Rad Power Bikes filed for Chapter 11 bankruptcy protection on Monday, weeks after it warned employees that it could shut down without new funding. The company will continue to ...

It’s a stunning fall for the once leading e-bike brand in the US. It’s a stunning fall for the once leading e-bike brand in the US. is transportation editor with 10+ years of experience who covers EVs ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Kurt Schlosser on Dec 17, 2025 at ...

Abstract: The single antenna bio-sensing (SABioS) method is investigated for noninvasive respiratory and cardiac activity monitoring. Using an antenna sensor installed over the chest of a subject, the ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Kurt Schlosser on Dec 16, 2025 at ...

SEATTLE (BRAIN) — Rad Power Bikes filed for Chapter 11 bankruptcy protection Monday in advance of completing a sale of the company and less than a month after it said it could not afford a recall on ...

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2025 /PRNewswire/ -- Link Cell Therapies ("Link"), an oncology cell therapy company, today announced its official launch from stealth with a $60 million Series A ...

– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocytosis Platform to discover first-in-class ...